Revenue (Quarterly) Chart

View Revenue (Quarterly) for CTEV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 257.48M
March 31, 2026 244.68M
December 31, 2025 246.55M
September 30, 2025 245.96M
June 30, 2025 241.57M
March 31, 2025 231.33M
December 31, 2024 232.14M
September 30, 2024 230.50M
June 30, 2024 233.48M
March 31, 2024 234.51M
December 31, 2023 244.14M
September 30, 2023 242.80M
June 30, 2023 237.99M
March 31, 2023 236.59M
Date Value
December 31, 2022 241.09M
September 30, 2022 250.45M
June 30, 2022 290.13M
March 31, 2022 298.05M
December 31, 2021 298.25M
September 30, 2021 288.21M
June 30, 2021 276.27M
March 31, 2021 254.86M
December 31, 2020 255.34M
September 30, 2020 223.52M
June 30, 2020 206.88M
March 31, 2020 252.02M
December 31, 2019 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 0.00
SCWorx Corp. 0.706M
Health Catalyst, Inc. 70.49M
GoodRx Holdings, Inc. 200.41M
iSpecimen, Inc. 0.1519M